Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Remote Surveillance Technologies: Realizing the Aim of Right Patient, Right Data, Right Time.

Safavi KC, Driscoll W, Wiener-Kronish JP.

Anesth Analg. 2019 Sep;129(3):726-734. doi: 10.1213/ANE.0000000000003948.

PMID:
31425213
2.

Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies.

Nagrebetsky A, Al-Samkari H, Davis NM, Kuter DJ, Wiener-Kronish JP.

Br J Anaesth. 2019 Jan;122(1):19-31. doi: 10.1016/j.bja.2018.09.010. Epub 2018 Oct 25. Review.

PMID:
30579402
3.

Remote Surveillance Technologies: Realizing the Aim of Right Patient, Right Data, Right Time.

Safavi KC, Driscoll W, Wiener-Kronish JP.

Anesth Analg. 2018 Nov 21. doi: 10.1213/ANE.0000000000003948. [Epub ahead of print]

PMID:
30489317
4.

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.

Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP, Bajwa EK, Donahoe MP, McVerry BJ, Ortiz LA, Exline M, Christman JW, Abbott J, Delucchi KL, Caballero L, McMillan M, McKenna DH, Liu KD.

Lancet Respir Med. 2019 Feb;7(2):154-162. doi: 10.1016/S2213-2600(18)30418-1. Epub 2018 Nov 16.

PMID:
30455077
5.

Intubation With Video Laryngoscopy vs Direct Laryngoscopy.

Saddawi-Konefka D, Baker KH, Wiener-Kronish JP.

JAMA. 2017 May 23;317(20):2130-2131. doi: 10.1001/jama.2017.4480. No abstract available.

PMID:
28535225
6.

Ensuring the Future of the Specialty: What Is the Best Strategy to Ensure a Pipeline of Physician-scientists?

Fleisher LA, Wiener-Kronish JP.

Anesthesiology. 2016 May;124(5):996-7. doi: 10.1097/ALN.0000000000001069. No abstract available.

PMID:
26928350
7.

Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.

Sawa T, Shimizu M, Moriyama K, Wiener-Kronish JP.

Crit Care. 2014 Dec 13;18(6):668. doi: 10.1186/s13054-014-0668-9. Review.

8.

New investigations of core competencies: perioperative mechanical ventilation and assessment of lung function.

Wiener-Kronish JP, Vidal Melo MF.

Anesthesiology. 2015 Apr;122(4):723-4. doi: 10.1097/ALN.0000000000000606. No abstract available.

9.

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome.

Liu KD, Wilson JG, Zhuo H, Caballero L, McMillan ML, Fang X, Cosgrove K, Calfee CS, Lee JW, Kangelaris KN, Gotts JE, Rogers AJ, Levitt JE, Wiener-Kronish JP, Delucchi KL, Leavitt AD, McKenna DH, Thompson BT, Matthay MA.

Ann Intensive Care. 2014 Jul 3;4:22. doi: 10.1186/s13613-014-0022-z. eCollection 2014.

10.

Telemedicine in the intensive care unit: effect of a remote intensivist on outcomes.

Wilcox ME, Wiener-Kronish JP.

JAMA Intern Med. 2014 Jul;174(7):1167-9. doi: 10.1001/jamainternmed.2014.289. No abstract available.

PMID:
24819239
11.

Rearrangement of a large novel Pseudomonas aeruginosa gene island in strains isolated from a patient developing ventilator-associated pneumonia.

Singh G, Srinivasan R, Cheng J, Peng Z, Fujimura K, Baek MS, Panzer AR, Tringe SG, Chen F, Sorek R, Weng L, Bristow J, Wiener-Kronish JP, Lynch SV.

J Clin Microbiol. 2014 Jul;52(7):2430-8. doi: 10.1128/JCM.01626-13. Epub 2014 Apr 30.

12.

Continuing aspirin in the perioperative patient.

Connors JM, Wiener-Kronish JP.

Ann Surg. 2012 May;255(5):820. doi: 10.1097/SLA.0b013e3182505069. No abstract available.

PMID:
22504186
13.

From microbe to microbiota: considering microbial community composition in infections and airway diseases.

Huang YJ, Lynch SV, Wiener-Kronish JP.

Am J Respir Crit Care Med. 2012 Apr 1;185(7):691-2. doi: 10.1164/rccm.201111-2030ED. No abstract available.

PMID:
22467799
14.

Is the evidence for benefits from ventilator-associated pneumonia bundles reliable enough for implementation in a general hospital?

Kalil AC, Wiener-Kronish JP.

Crit Care Med. 2012 Jan;40(1):348-50. doi: 10.1097/CCM.0b013e318236ec24. No abstract available.

PMID:
22179378
15.

Strain-dependent induction of neutrophil histamine production and cell death by Pseudomonas aeruginosa.

Xu X, Zhang H, Song Y, Lynch SV, Lowell CA, Wiener-Kronish JP, Caughey GH.

J Leukoc Biol. 2012 Feb;91(2):275-84. doi: 10.1189/jlb.0711356. Epub 2011 Nov 10.

16.

Therapies against virulence products of Staphylococcus aureus and Pseudomonas aeruginosa.

Wiener-Kronish JP, Pittet JF.

Semin Respir Crit Care Med. 2011 Apr;32(2):228-35. doi: 10.1055/s-0031-1275535. Epub 2011 Apr 19. Review.

PMID:
21506059
17.

Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients.

Fricks-Lima J, Hendrickson CM, Allgaier M, Zhuo H, Wiener-Kronish JP, Lynch SV, Yang K.

Int J Antimicrob Agents. 2011 Apr;37(4):309-15. doi: 10.1016/j.ijantimicag.2010.12.017. Epub 2011 Mar 5.

18.

Newer technology is not always better.

Albrecht M, Wiener-Kronish JP.

Crit Care Med. 2011 Mar;39(3):591-2. doi: 10.1097/CCM.0b013e31820c6c01. No abstract available.

PMID:
21330860
19.

Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

J Allergy Clin Immunol. 2011 Feb;127(2):372-381.e1-3. doi: 10.1016/j.jaci.2010.10.048. Epub 2010 Dec 30.

20.

Joseph Adrian Jeevendra Martyn, M.D., F.R.C.A., F.C.C.M., recipient of the 2010 Excellence in Research Award.

Wiener-Kronish JP.

Anesthesiology. 2010 Sep;113(3):524-5. No abstract available.

PMID:
20862777
21.

Secretion of Pseudomonas aeruginosa type III cytotoxins is dependent on pseudomonas quinolone signal concentration.

Singh G, Wu B, Baek MS, Camargo A, Nguyen A, Slusher NA, Srinivasan R, Wiener-Kronish JP, Lynch SV.

Microb Pathog. 2010 Oct;49(4):196-203. doi: 10.1016/j.micpath.2010.05.013. Epub 2010 Jun 2.

22.

Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV - implications for anti-PcrV immunotherapy.

Lynch SV, Flanagan JL, Sawa T, Fang A, Baek MS, Rubio-Mills A, Ajayi T, Yanagihara K, Hirakata Y, Kohno S, Misset B, Nguyen JC, Wiener-Kronish JP.

Microb Pathog. 2010 Jun;48(6):197-204. doi: 10.1016/j.micpath.2010.02.008. Epub 2010 Mar 6.

23.

A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.

Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV.

OMICS. 2010 Feb;14(1):9-59. doi: 10.1089/omi.2009.0100.

24.

Effect of ventilator-induced lung injury on skeletal muscle oxidative balance.

Musch G, Wiener-Kronish JP.

Anesthesiology. 2010 Feb;112(2):279-81. doi: 10.1097/ALN.0b013e3181c38de1. No abstract available.

PMID:
20098126
25.

Mechanisms of bacterial virulence in pulmonary infections.

Moskowitz SM, Wiener-Kronish JP.

Curr Opin Crit Care. 2010 Feb;16(1):8-12. doi: 10.1097/MCC.0b013e3283354710. Review.

26.

Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.

Moriyama K, Wiener-Kronish JP, Sawa T.

Microbiol Immunol. 2009 Nov;53(11):587-94. doi: 10.1111/j.1348-0421.2009.00165.x.

27.

Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program.

Feldman MD, Huang L, Guglielmo BJ, Jordan R, Kahn J, Creasman JM, Wiener-Kronish JP, Lee KA, Tehrani A, Yaffe K, Brown JS.

Clin Transl Sci. 2009 Jun;2(3):216-21. doi: 10.1111/j.1752-8062.2009.00120.x.

28.

The United States critical illness and injury trials group: an introduction.

Cobb JP, Cairns CB, Bulger E, Wong HR, Parsons PE, Angus DC, Gentile NT, Hoyt DB, Schwinn DA, Wiener-Kronish JP, Upperman JS.

J Trauma. 2009 Aug;67(2 Suppl):S159-60. doi: 10.1097/TA.0b013e3181ad3473.

PMID:
19667851
29.

Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia.

El-Solh AA, Amsterdam D, Alhajhusain A, Akinnusi ME, Saliba RG, Lynch SV, Wiener-Kronish JP.

J Infect. 2009 Jul;59(1):49-55. doi: 10.1016/j.jinf.2009.05.004. Epub 2009 May 23.

30.

An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity.

Baer M, Sawa T, Flynn P, Luehrsen K, Martinez D, Wiener-Kronish JP, Yarranton G, Bebbington C.

Infect Immun. 2009 Mar;77(3):1083-90. doi: 10.1128/IAI.00815-08. Epub 2008 Dec 22.

31.

2008 in review: advancing medicine in anesthesiology.

Eisenach JC, Borgeat A, Bosnjak ZJ, Brennan TJ, Kersten JR, Kochs E, Lerman J, Warner DS, Wiener-Kronish JP.

Anesthesiology. 2008 Dec;109(6):962-72. doi: 10.1097/ALN.0b013e31818e4149. No abstract available.

PMID:
19034092
32.

Depletion of phagocytes in the reticuloendothelial system causes increased inflammation and mortality in rabbits with Pseudomonas aeruginosa pneumonia.

Kurahashi K, Sawa T, Ota M, Kajikawa O, Hong K, Martin TR, Wiener-Kronish JP.

Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L198-209. doi: 10.1152/ajplung.90472.2008. Epub 2008 Nov 21.

33.

Ventilator-associated pneumonia: problems with diagnosis and therapy.

Wiener-Kronish JP, Dorr HI.

Best Pract Res Clin Anaesthesiol. 2008 Sep;22(3):437-49. Review.

34.

Novel strategies to combat bacterial virulence.

Lynch SV, Wiener-Kronish JP.

Curr Opin Crit Care. 2008 Oct;14(5):593-9. doi: 10.1097/MCC.0b013e32830f1dd5. Review.

35.

Role of small GTPases and alphavbeta5 integrin in Pseudomonas aeruginosa-induced increase in lung endothelial permeability.

Ganter MT, Roux J, Su G, Lynch SV, Deutschman CS, Weiss YG, Christiaans SC, Myazawa B, Kipnis E, Wiener-Kronish JP, Howard M, Pittet JF.

Am J Respir Cell Mol Biol. 2009 Jan;40(1):108-18. doi: 10.1165/rcmb.2007-0454OC. Epub 2008 Aug 14.

36.

Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection.

Zhuo H, Yang K, Lynch SV, Dotson RH, Glidden DV, Singh G, Webb WR, Elicker BM, Garcia O, Brown R, Sawa Y, Misset B, Wiener-Kronish JP.

Crit Care Med. 2008 Sep;36(9):2495-503. doi: 10.1097/CCM.0b013e318183f3f8.

PMID:
18679122
37.

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

El Solh AA, Akinnusi ME, Wiener-Kronish JP, Lynch SV, Pineda LA, Szarpa K.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):513-9. doi: 10.1164/rccm.200802-239OC. Epub 2008 May 8.

38.

Role of integrin alphav beta6 in acute lung injury induced by Pseudomonas aeruginosa.

Song Y, Pittet JF, Huang X, He H, Lynch SV, Violette SM, Weinreb PH, Horan GS, Carmago A, Sawa Y, Bernstein XL, Wiener-Kronish JP.

Infect Immun. 2008 Jun;76(6):2325-32. doi: 10.1128/IAI.01431-07. Epub 2008 Mar 31.

39.

Treating lung infections with anticoagulation: mechanisms matter.

Pittet JF, Song Y, Wiener-Kronish JP.

Crit Care Med. 2008 Jan;36(1):356-7. No abstract available.

PMID:
18158457
40.

2007 in review: a dozen steps forward in Anesthesiology.

Eisenach JC, Borgeat A, Bosnjak ZJ, Brennan TJ, Kersten JR, Kochs EF, Wiener-Kronish JP.

Anesthesiology. 2008 Jan;108(1):149-55. Review. No abstract available.

PMID:
18156893
41.

Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa.

Flanagan JL, Brodie EL, Weng L, Lynch SV, Garcia O, Brown R, Hugenholtz P, DeSantis TZ, Andersen GL, Wiener-Kronish JP, Bristow J.

J Clin Microbiol. 2007 Jun;45(6):1954-62. Epub 2007 Apr 4.

42.

Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model.

Imamura Y, Yanagihara K, Fukuda Y, Kaneko Y, Seki M, Izumikawa K, Miyazaki Y, Hirakata Y, Sawa T, Wiener-Kronish JP, Kohno S.

Eur Respir J. 2007 May;29(5):965-8. Epub 2007 Feb 14.

43.

Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa.

Song Y, Lynch SV, Flanagan J, Zhuo H, Tom W, Dotson RH, Baek MS, Rubio-Mills A, Singh G, Kipnis E, Glidden D, Brown R, Garcia O, Wiener-Kronish JP.

Anesthesiology. 2007 Feb;106(2):252-61.

PMID:
17264718
44.

Alveolar hemostasis in patients with species-specific bacterial-mediated ventilator-associated pneumonia.

Song Y, Wiener-Kronish JP, Flanagan J, Lynch SV.

Crit Care Med. 2007 Feb;35(2):652-3. No abstract available.

PMID:
17251717
45.

Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.

Augustin DK, Song Y, Baek MS, Sawa Y, Singh G, Taylor B, Rubio-Mills A, Flanagan JL, Wiener-Kronish JP, Lynch SV.

J Bacteriol. 2007 Mar;189(6):2203-9. Epub 2007 Jan 5.

46.

Beta-2-agonist treatment as a potential therapy for acute inhalational lung injury.

Wiener-Kronish JP, Matthay MA.

Crit Care Med. 2006 Jun;34(6):1841-2. No abstract available.

PMID:
16714996
47.

Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.

Neely AN, Holder IA, Wiener-Kronish JP, Sawa T.

Burns. 2005 Mar;31(2):153-8.

PMID:
15683685
48.

Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.

Pankhaniya RR, Tamura M, Allmond LR, Moriyama K, Ajayi T, Wiener-Kronish JP, Sawa T.

Crit Care Med. 2004 Nov;32(11):2293-9.

PMID:
15640644
49.

A therapeutic strategy against the shared virulence mechanism utilized by both Yersinia pestis and Pseudomonas aeruginosa.

Sawa T, Wiener-Kronish JP.

Anesthesiol Clin North Am. 2004 Sep;22(3):591-606, viii-ix. Review.

PMID:
15325721
50.

V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa.

Allmond LR, Ajayi T, Moriyama K, Wiener-Kronish JP, Sawa T.

J Clin Microbiol. 2004 Aug;42(8):3857-60.

Supplemental Content

Loading ...
Support Center